Therefore, activated tumor antigen-specific CD8+T cells can easily recognize new antigens through the homologous T cell receptor (TCR) and eliminate tumor cells by using the effector mechanism, including the production of inflammatory cytokines and cytotoxic particles (Step 12) [107]. Here, CD8A is linked to neoplasm.